Related Experiment Video

Updated: May 17, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Durable complete remission with abiraterone in castration resistant metastatic prostate cancer

Binay Kumar Shah, Sunita Shrestha

    Acta Oncologica (Stockholm, Sweden)
    |November 6, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Retzius-Sparing Robot-Assisted Radical Prostatectomy
    12:10

    Retzius-Sparing Robot-Assisted Radical Prostatectomy

    Published on: May 19, 2022

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    Related Experiment Videos

    Last Updated: May 17, 2026

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
    07:25

    A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

    Published on: March 6, 2018

    Retzius-Sparing Robot-Assisted Radical Prostatectomy
    12:10

    Retzius-Sparing Robot-Assisted Radical Prostatectomy

    Published on: May 19, 2022

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Type II alveolar epithelial cell-specific CAP1 loss is associated with spontaneous pulmonary fibrosis and altered complement 5 signaling.

    BMC pulmonary medicine·2026

    Rapidly Progressive Guillain-Barré Syndrome (GBS) as a Critical Predictor of Early Mechanical Ventilation and Prolonged Hospitalization: An Observational Study at a Tertiary Care Hospital.

    Cureus·2025

    Aging in place or aging out of place? Family caregivers' perspectives on care for older Pakistani migrants in Norway.

    European journal of ageing·2024

    The Morality of Care: Female Family Caregivers' Motivations for Providing Care to Older Migrants.

    Qualitative health research·2024

    Intergenerational ambivalence among families with a migrant background caring for older relatives.

    Journal of migration and health·2024

    Minimally invasive approaches versus conventional sternotomy for aortic valve replacement in patients with aortic valve disease: a systematic review and meta-analysis of 17 269 patients.

    Annals of medicine and surgery (2012)·2024

    Prognostic significance of isolated tumor cells and nodal tumor burden in endometrial cancer: a population-based cohort study.

    Acta oncologica (Stockholm, Sweden)·2026

    Improving cervical cancer screening uptake through theory-informed education: a comprehensive systematic review and meta-analysis.

    Acta oncologica (Stockholm, Sweden)·2026

    The Clinical outcomes following pencil beam scanning proton therapy for skull base chordoma and chondrosarcoma: a single-institution experience.

    Acta oncologica (Stockholm, Sweden)·2026

    User perceptions of machine learning models as decision support for colorectal cancer multidisciplinary team conferences (AID-SIM-2): a qualitative simulation study.

    Acta oncologica (Stockholm, Sweden)·2026

    Estimated number of children affected by paternal cancer diagnosis and death in Finland during 1970-2022: a population-based registry study.

    Acta oncologica (Stockholm, Sweden)·2026

    The impact of pazopanib and extremity radiotherapy on transaminase elevations in soft tissue sarcoma.

    Acta oncologica (Stockholm, Sweden)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us